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method. All the tested hybrids showed good anti-inﬂammatory activity with 64.78–86.03% inhibi-
tion of edema. Most active hybrids 4b and 4f were further investigated for antihistaminic H1 [4b
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lg/mL (16.04 lM); 4f 9.64 lg/mL (25.04 lM)] activities. Molecule 4f with anti-inﬂammatory,
anti-histaminic and anti-serotonergic activities emerges as a potential anti-inﬂammatory lead form
in this study.
ª 2014 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Inﬂammation is deﬁned as a complex defensive process, in
which the body responds to different injuries, and is character-
ized by the accumulation of local ﬂuids and leukocytes with
the objective of eliminating the noxious stimulus. In patholog-
ical conditions the evolution of persistent tissue damage by
inﬂammatory cells is not suitably repaired (Nathan, 2002;
Thorlacius and Xie, 1995). Histamine and serotonin arehybrids
2 R.A. Rane et al.considered to be some of the most important mediators of
inﬂammation. During inﬂammation, histamine is involved in
vasodilatation, promotion of leukocyte adhesion to the vascu-
lar endothelium through the expression of P-selectin on the
endothelial cell surface and sequestration of leukocytes at the
inﬂammatory site (Thorlacius and Xie, 1995; Asako et al.,
1994). Histamine-mediated inﬂammatory responses have long
been thought to be mediated by the histamine H1 receptor.
Likewise, pro-inﬂammatory role of serotonin (5-HT) as a
mediator of the pain has been widely investigated. Serotonin
promotes the production of interferon-c by human natural
killer cells. Out of many serotonergic receptors, peripheral
5-HT3 receptors are involved in various nociceptive pathways
(Ye et al., 1997). This subtype of serotonergic receptors also
plays a crucial role in spinal pain transmission as well as
endogenous pain suppression. A large body of evidence impli-
cates the efﬁcacy of 5-HT3 antagonists in various inﬂamma-
tory conditions including rheumatic diseases (Samborski
et al., 2004).
Carrageenan, a sulphated polysaccharide, produces inﬂam-
mation and edema. Therefore, carrageenan-induced paw
edema is a well established and broadly used model of acute
inﬂammation for evaluation of anti-inﬂammatory activities
of different test substances (Winter et al., 1962). Carrageenan
produces inﬂammation and edema in two phases. The early
phase is observed around 1 h where the release of histamine,
serotonin, bradykinin and to some extent prostaglandins takes
place. Second phase i.e. the delayed phase (after 1 h) is where
polymorphonuclear (PMN) leucocyte inﬁltration and the con-
tinuous generation of the prostaglandin occur (Gilligan and
Lovato, 1994; Di Rosa et al., 1971a, 1971b). In addition to
these, release of PMN leucocyte-derived free radicals, nitric
oxide (NO), tumor necrosis factor (TNF-a), and interleukin-
1b (IL-1) also takes place in the delayed phase (Halici et al.,
2007; Nacife et al., 2004).
A diverse set of molecules with different pharmacophores
have been explored in search of novel anti-inﬂammatory agents
using carrageenan-induced paw edema as a model for acute
inﬂammation. Among them aroyl hydrazones are known for
having anti-inﬂammatory activity (Bhandari et al., 2008;
Rajitha et al., 2011). Aroyl hydrazones constitute an important
class of privileged scaffold for new drug development. They are
known to possess a diverse array of biological effects like anti-
convulsant, analgesic, antidepressant, antibacterial, antifungal,
antimalarial and antitumor activities (Go¨kc¸e et al., 2009).
We are currently working on the design, synthesis and eval-
uation of bromopyrrole alkaloid-based derivatives as antimi-
crobial and anticancer agents (Rane et al., 2012a,b, 2013a,b,
2014a). Bromopyrrole alkaloids are naturally occurring marine
compounds found inmarine sponges (Rane et al., 2014b). These
alkaloids are reported to have a diverse set of pharmacological
activities like antibacterial, antitubercular (Tasdemir et al.,
2007), anitibioﬁlm (Richards et al., 2008), antineoplastic
(Xiong et al., 2010; Tasdemir et al., 2002) and antiviral agents
(Paul et al., 1991; Tsuda et al., 2006). Importantly these natural
products also possess H1 anti-histaminic activity, where 1 and
0.1 lM response of histamine was almost completely abolished
by 3 and 10 lM solution of III and IV respectively (Aiello et al.,
2008; Caﬁeri et al., 1996; Fattorusso and Taglialatela-Scafati,
2000). V and VI were reported as having antiserotonergic
(5-HT3 antagonistic) activity on isolated guinea pig ileum
(Morales and Rodriguez, 1991; Caﬁeri et al., 1995). SimilarlyPlease cite this article in press as: Rane, R.A. et al., Synthesis and pharm
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inhibition of P2X7 (Buchanan et al., 2007). (Fig. 1a) Looking
into the pharmacological potential of these reported molecules,
we indulged ourselves in the synthesis and evaluation of hybrids
of bromopyrrole alkaloids with the aroyl hydrazone feature as
anti-inﬂammatory agents using the carrageenan-induced paw
edema technique. (Fig. 1b) To ﬁnd out the underlying mecha-
nism of observed anti-inﬂammatory effect, we screened most
effective hybrids of the series for their histamine H1 and
5-HT3 receptor antagonistic activities by using in-vitro tissue
assays.
2. Methods and materials
2.1. Chemistry
All reactions were carried out under an inert nitrogen atmo-
sphere under anhydrous conditions and by using molecular
sieves (4 A˚ 1/1600 pellets), ethanol and CAN (acetonitrile) were
freshly distilled from CaCl2. All chromatographic solvents were
distilled before use. Silica gel of 60–120 mesh and 200–400 mesh
was used for column and ﬂash chromatography. Some of the
starting materials were obtained from S.D. Fine Pvt. Ltd.,
SRL, Spectrochem/Aldrich and some of them are prepared in
the laboratory and were used without further puriﬁcation. All
melting points (MP) were recorded on Thermomik Compbell
electronics, having an oil-heating system and were uncorrected.
Analytical thin layer chromatography (TLC) was carried out
on precoated plates SiO2 (silica gel 60, F 254, Merck). FTIR
spectra were recorded on a Perkin Elmer RX I spectrometer
using KBr pellets. All the NMR spectra were recorded on
JEOL AL-300 FT-NMR spectrometer with DMSO-d6 as sol-
vent using tetramethyl silane (TMS) as internal reference. Mass
spectra were obtained on THERMO FINNINGAN LCQ
advantage max (LCMS). Compounds 1, 2 and 3 were prepared
according to the reported methods (Rane et al., 2012a,b,
2013a,b). Evaporation of ﬁnal product solutions was done
under vacuum with a rotary evaporator.
2.2. Synthesis of 4,5-dibromo-N0-arylidene-1H-pyrrole-2-
carbohydrazide analogs (4)
Appropriate aldehydes (27.5 mmol), and 3 (6, 27.5 mmol), were
stirred in 30 mL absolute ethanol in a round bottomed ﬂask.
1–2 mL of triethylamine was added to the reaction mixture
and was reﬂuxed for 4–7 h. Most of the 4,5-dibromo-1-
methyl-1H-pyrrole-2-carbohydrazide was consumed at this
time (monitored by TLC), the reaction mixture was concen-
trated under reduced pressure and the obtained solid residue
was partitioned between 50 mL water and 50 mL chloroform
to extract 4 in organic layer. Column puriﬁcation using ﬂash
chromatography (SiO2, 10% MeOH /CHCl3) of the crude
product yielded pure 4,5-dibromo-N0-arylidene-1-methyl-1H-
pyrrole-2-carbohydrazide. The obtained solid was recrystal-
lized from MeOH.
4,5-Dibromo-N0-(furan-2-ylmethylene)-1H-pyrrole-2-car-
bohydrazide (4a) Yield: 78%; m.p.: 188–190 C; IR (KBr):
Vmax cm
1 1622 (C‚C), 1648 (CH‚N), 1725 (C‚O), 3214
(NH); 1H NMR (300 MHz, DMSO-d6): d 6.62 (s, 1H pyrrole
3H), 6.91–7.33 (m, 3H ArH), 8.21 (s, 1H azometine H),
11.51 (s, 1H CONH), 13.00 (s, 1H pyrrole NH); 13C NMRacological evaluation of marine bromopyrrole alkaloid-based hybrids
p://dx.doi.org/10.1016/j.arabjc.2014.06.004
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Figure 1a Reported aroyl hydrazones and bromopyrrole alkaloids with their biological activities.
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Figure 1b Design of novel N0-arylidene-4,5-dibromo-1H-pyr-
role-2-carbohydrazides using the molecular hybridization
approach.
Synthesis and evaluation of marine bromopyrrole alkaloid-based hybridspharmacological evaluation 3(75 MHz, DMSO-d6): d 157.3, 149.2, 144, 135.6, 126.3, 118.2,
113.2, 112.9, 106.3, 100.2; MS m/z: 359.8908 [M]+, 361.8911
[M+2]+,363.8915 [M+4]+.
4,5-Dibromo-N0-(2,6-dichlorobenzylidene)-1H-pyrrole-2-
carbohydrazide (4b) (Rane et al., 2014a) Yield: 78%; m.p.:
232–234 C; IR (KBr): Vmax cm1 1626 (C‚C), 1643
(CH‚N), 1723 (C‚O), 3219 (NH); 1H NMR (300 MHz,
DMSO-d6): d 7.14 (s, 1H pyrrole 3H), 7.52–8.00 (m, 3H
ArH), 8.68 (s, 1H azometine H), 11.84 (s, 1H CONH), 13.08
(s, 1H pyrrole NH); 13C NMR (75 MHz, DMSO-d6): d
157.1, 138.3, 133.6, 129.5, 128.2, 126.3, 114.2, 106.3, 100.2;
MS m/z: 437.8331 [M]+, 439.8335 [M+2]+, 441.8339 [M+4]+.Please cite this article in press as: Rane, R.A. et al., Synthesis and pharm
with anti-inﬂammatory activity. Arabian Journal of Chemistry (2014), htt4,5-Dibromo-N0-(4-(dimethylamino)benzylidene)-1H-pyr-
role-2-carbohydrazide (4c) Yield: 80%; m.p.: 216–218 C; IR
(KBr): Vmax cm
1 1626 (C‚C), 1640 (CH‚N), 1714
(C‚O), 3214 (NH); 1H NMR (300 MHz, DMSO-d6): d
3.25–3.40 (s, 6H CH3), 7.02 (s, 1H pyrrole 3H), 7.19–7.49
(m, 4H ArH), 8.64 (s, 1H azometine H), 11.54 (s, 1H CONH),
12.96 (s, 1H pyrrole NH); 13C NMR (75 MHz, DMSO-d6): d
157.4, 153.6, 146.3, 128.2, 126.3, 123.6, 114, 112.1, 106.3,
100.3, 41.9; MS m/z: 412.9536 [M]+, 414.9540 [M+2]+,
428.9546 [M+4]+.
4,5-Dibromo-N0-(4-ﬂuorobenzylidene)-1H-pyrrole-2-car-
bohydrazide (4d) (Rane et al., 2014a) Yield: 74%; m.p.: 156–
158 C; IR (KBr): Vmax cm1 1612 (C‚C), 1648 (CH‚N),
1722 (C‚O), 3216 (NH); 1H NMR (300 MHz, DMSO-d6): d
7.12 (s, 1H pyrrole 3H), 7.29-7.95 (m, 4H ArH), 8.73 (s, 1H
azometine H), 11.59 (s, 1H CONH), 13.02 (s, 1H pyrrole
NH); 13C NMR (75 MHz, DMSO-d6): d 165.5, 157.2, 146.3,
130.2, 129.2, 126.9, 115.4, 113.2, 106.6, 100.3; MS m/z:
387.9021 [M]+, 389.9024 [M+2]+, 386.9026 [M+4]+.
4,5-Dibromo-N0-(4-hydroxybenzylidene)-1H-pyrrole-2-car-
bohydrazide (4f) (Rane et al., 2014a) Yield: 88%; m.p.: 212–
214 C; IR (KBr): Vmax cm1 1624 (C‚C), 1643 (CH‚N),
1719 (C‚O), 3222 (NH), 3452 (OH); 1H NMR (300 MHz,
DMSO-d6): d 6.82 (s, 1H pyrrole 3H), 6.85 -7.56 (m, 4H
ArH), 8.23 (s, 1H azometine H), 9.93 (s, 1H OH), 11.34 (s,
1H CONH), 12.84 (s, 1H pyrrole NH); 13C NMR (75 MHz,
DMSO-d6): d 160.3, 157.6, 146.2, 130.2, 126.9, 126.3, 116.2,acological evaluation of marine bromopyrrole alkaloid-based hybrids
p://dx.doi.org/10.1016/j.arabjc.2014.06.004
4 R.A. Rane et al.114.1, 106.5, 100.3; MS m/z: 385.9065 [M]+, 387.9067 [M+2]+,
389.9071 [M+4]+.
4,5-Dibromo-N0-(thiophen-2-ylmethylene)-1H-pyrrole-2-
carbohydrazide (4j) Yield: 78%; m.p.: 230–232 C; IR (KBr):
Vmax cm
1 1626 (C‚C), 1632 (CH‚N), 1716 (C‚O), 3228
(NH); 1H NMR (300 MHz, DMSO-d6): d 6.47 (s, 1H pyrrole
3H), 6.90-7.47 (m, 4H ArH), 8.16 (s, 1H azometine H), 11.21
(s, 1H CONH), 12.92 (s, 1H pyrrole NH); 13C NMR
(75 MHz, DMSO-d6): d 157.6, 144.5, 130.1, 128.1, 127.6,
126.2, 124.9, 113.9, 106.5, 100.1; MS m/z: 375.8678 [M]+,
377.8681 [M+2]+, 379.8683 [M+4]+.
4,5-Dibromo-N0-(3,4-dimethoxybenzylidene)-1H-pyrrole-2-
carbohydrazide (4l) (Rane et al., 2014a) Yield: 85%; m.p.: 134-
136 C; IR (KBr): Vmax cm1 1622 (C‚C), 1643 (CH‚N),
1716 (C‚O), 3234 (NH); 1H NMR (300 MHz, DMSO-d6): d
3.25 (s, 3H OCH3), 3.40 (s, 3H OCH3), 6.76 (s, 1H pyrrole
3H), 7.07 7.50 (m, 3H ArH), 8.19 (s, 1H azometine H),
11.26 (s, 1H CONH), 12.91 (s, 1H pyrrole NH); 13C NMR
(75 MHz, DMSO-d6): d 157.6, 152.2, 149.6, 145.9, 132.2,
126.5, 122.1, 114, 112.1, 109.6, 105.9, 100.6, 56.2; MS m/z:
429.9329 [M]+, 431.9332 [M+2]+, 433.9336 [M+4]+.
4,5-Dibromo-N0-(2,5-dihydroxybenzylidene)-1H-pyrrole-2-
carbohydrazide (4n) Yield:80%; m.p.: 230–232 C; IR (KBr):
Vmax cm
1 1621 (C‚C), 1642 (CH‚N), 1719 (C‚O), 3229
(NH), 3480 (OH); 1H NMR (300 MHz, DMSO-d6): d 6.77
(s, 1H pyrrole 3H), 6.91–7.29 (m, 3H ArH), 8.14 (s, 1H azome-
tine H), 9.29 (s, 1H 5-OH), 9.47 (s, 1H 2-OH), 11.33 (s, 1H
CONH), 12.95 (s, 1H pyrrole NH); 13C NMR (75 MHz,
DMSO-d6): d 157.2, 153.6, 151.9, 146.9, 126.5, 120.2, 118.9,
116.1, 113.6, 106.2, 100.3; MS m/z: 401.9018 [M]+, 403.9019
[M+2]+, 405.9021 [M+4]+.
2.3. Pharmacological evaluation
2.3.1. Animal
Male Wistar rats (150 to 200 g; 10 to 12 weeks old) were used
in the study. The animals were housed in polyacrylic cages
(38 · 23 · 10 cm) with not more than four rats per cage and
acclimatized to the laboratory conditions before randomiza-
tion. They were housed in an air-conditioned room and were
kept in standard laboratory conditions under natural light
and dark cycles (approximately 14 h light: 10 h dark) main-
tained at humidity of 50 ± 10% and an ambient temperature
of 25 ± 2 C. The study protocol was reviewed and approved
by the Institutional Animal Ethics Committee and conforms to
the Indian National Science Academy Guidelines for the Use
and Care of Experimental Animals in research.
2.3.2. Anti-inﬂammatory activity
This study was done according to the procedure of Winter
(Winter et al., 1962). Animals were fasted with free access to
water at least 12 h prior to experiments and randomly divided
into groups with six animals in each group. The paw edema
was induced by sub-plantar injection of 50 lL of 1% carra-
geenan solution in 0.9% saline. Indomethacin and the test
compounds were dissolved in DMSO and were injected subcu-
taneously in a dose of 40 mg/kg body weight 1 h prior to car-
rageenan injection. The control group was prepared with 1 mL
of vehicle (0.9% saline and DMSO). The paw edema volume
was measured with a digital plethysmometer immediately at,
1, 2, and 4 h after injection of carrageenan. Results arePlease cite this article in press as: Rane, R.A. et al., Synthesis and pharm
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volume was compared with the vehicle control group and per-
cent anti-inﬂammatory activity was calculated according to the
formula as given below. The result is expressed as percentage
inhibition of edema over the untreated control group. The
result of anti-inﬂammatory analysis is reported in Table 1.
The percentage inhibition ¼ 1 ðEdema volume in the drug treated group
=Edema volume in the control groupÞ  100:2.3.3. In vitro H1-antihistaminic and 5HT3-antiserotonergic
activity: (Isolated guinea pig ileum method)
In vitroH1-antihistaminic and 5HT3-antiserotonergic activities
were carried out by using the isolated guinea pig ileum method
(Day and Vane, 1963). From the graphical presentation of log-
arithmic doses of test compounds and their corresponding
antagonists, IC50 of the agonist response was determined.
Mepyramine maleate and Ondansetron hydrochloride were
used as standard antihistaminic and antiserotonergic agents,
respectively.
2.4. Statistical analysis of data
Data obtained from animal experiments were expressed as
mean standard error (±SEM). Statistical differences between
the treatments and the control were evaluated by ANOVA
and Dunnet tests. p< 0.05 was considered to be statistically
signiﬁcant. [*p< 0.05; **p< 0.01; ***p< 0.001].
3. Results and discussion
3.1. Chemistry
Aroyl hydrazones were synthesized as depicted in the Scheme 1.
Compounds 1, 2 and 3 were already reported by us in our pre-
viously communicated papers (Rane et al., 2012a,2b, 2013a,b).
The aroyl hydrazone derivatives were synthesized by reﬂuxing
equimolar amounts of 3 with aryl/heteroaryl aldehydes in
the presence of triethylamine in ethanol to give the desired
4,5-dibromo-N0-arylidene-1H-pyrrole-2-carbohydrazide ana-
logs 4 (Scheme 1).
The spectral data (IR, 1H NMR, 13C NMR and MS) of the
synthesized compounds were in complete agreement with
the proposed structures. [M]+ Molecular ion peak conﬁrmed
the molecular weight of the compounds while [M+2]+ and
[M+4]+ peaks conﬁrmed the presence of two bromine atoms
in these molecules. The 1H NMR spectra of all compounds
4a–4n showed single at d 12.8–13.0 corresponding to N–H of
the pyrrole core. Proton at the third position of the pyrrole
core resonates at d 6.1–7.1 N–H proton of -CONHN‚CH-
group resonates in between d 11.2 – 11.5. The azometine pro-
ton to which the aromatic ring B is attached showed a singlet
at around d 8.1–8.7. The aryl protons of ring B resonates in the
range of d 6.9–7.9.
3.2. Pharmacological activity
In present study, preliminary screening of the synthesized
hybrids was carried out using carrageenan-induced paw
edema as model of inﬂammation in rats at a dose of 40 mg/kgacological evaluation of marine bromopyrrole alkaloid-based hybrids
p://dx.doi.org/10.1016/j.arabjc.2014.06.004
Table 1 Anti-inﬂammatory activity of hybrids in carrageenan-induced rat paw model.a,b
Hybrid code Treatment
(n= 6) 1 h 2 h 4 h
R Swelling % inhc Swelling % inhc Swelling % inhc
Control 3.09 ± 0.10 – 3.87 ± 0.09 – 4.82 ± 0.10 –
4a Furan- 2.63 ± 0.06* 57.14 2.80 ± 0.08* 69.00 2.35 ± 0.10* 79.57
4b 2,6-Dichlorophenyl- 2.40 ± 0.07* 55.06 2.60 ± 0.09* 60.00 2.10 ± 0.06* 85.07
4c (4-Dimethylamino) phenyl- 2.88 ± 0.10 40.74 3.15 ± 0.12 45.07 2.71 ± 0.07* 68.89
4d 4-Fluorophenyl- 2.55 ± 0.08* 37.99 2.40 ± 0.08* 38. 01 2.70 ± 0.15* 64.78
4f 4-Hydroxyphenyl- 2.63 ± 0.09* 64.89 2.70 ± 0.10* 63.98 2.09 ± 0.11* 86.03
4j Thiophen- 2.71 ± 0.11* 63.36 2.71 ± 0.16* 63.87 2.41 ± 0.08* 67.61
4l 3,4-Dimethoxyphenyl- 2.92 ± 0.04 52.30 3.72 ± 0.05 48.15 4.15 ± 0.08 67.14
4n 2,5-Dihydroxyphenyl-Indomethacin 2.93 ± 0.09 53.41 3.69 ± 0.06 45.15 4.29 ± 0.11 65.11
2.48 ± 0.18* 70.2 2.42 ± 0.15* 78.30 2.29 ± 0.15* 87.26
* p< 0.05 versus saline control; n= 6.
a Values are expressed as mean ± SEM in carrageenan-induced rat model of paw edema.
b Indomethacin and test compounds were administered orally at the dose of 40 mg/kg.
c The percentage inhibition = 1  (Edema volume in the drug treated group/Edema volume in the control group) · 100.
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Synthesis and evaluation of marine bromopyrrole alkaloid-based hybridspharmacological evaluation 5(Winter et al., 1962). The biological results are given in Table 1.
All the synthesized hybrids exhibited moderate to good anti-
inﬂammatory activity with 64.78–86.03% inhibition of carra-
geenan-induced paw edema. The hybrid with para-hydroxyl
substitution at ring B (4f, 86.03%) has shown highest activity
in the series close to standard Indomethacin (87.26%). Signif-
icant anti-inﬂammatory activities showed by hybrids 4c
(68.89%) and 4f (86.03%) indicated that the presence of sub-
stituents like hydroxyl and N, N-dimethylamino at the para-
position of the phenyl ring is beneﬁcial for activity. Among
the heterocyclic congener of ring B, furan substituted hybrid
4a showed better anti-inﬂammatory activity (79.57%) com-
pared to its thiophen substituted analog 4j (67.61%). Substitu-
tion of phenyl ring at 2 and 6-positions with the chloro group
is beneﬁcial for anti-inﬂammatory activity (4b, 85.07%). Fur-
ther, anti-inﬂammatory potential of most active hybrids 4f
was validated by evaluating its starting materials; 4-hydroxy-
bezaldehyde and 4,5-dibromopyrrole-2-carbohydrazide for
inhibition of carrageenan-induced paw edema. Both of them
exhibited lower anti-inﬂammatory activity (edema inhibition
<40%). Phenolic compounds are well known for their anti-
inﬂammatory potential (Lee et al., 2006). High activity of 4f
may be attributed to the presence of phenolic substitution atPlease cite this article in press as: Rane, R.A. et al., Synthesis and pharm
with anti-inﬂammatory activity. Arabian Journal of Chemistry (2014), httthe ring B position. Considering the antihistaminic H1 and
antiserotonergic HT3 potentials of reported bromopyrrole
alkaloid molecules and with a goal to investigate the underly-
ing mechanism of anti-inﬂammatory action of synthesized
hybrids, most active compounds of the series, 4b and 4f were
evaluated for H1-antihistaminic and 5HT3-antiserotonergic
activities. H1-antihistaminic activity, IC50 of the 4b and 4f
derivatives were 8.09 (18.5 lM) and 9.26 lg/mL (24.05 lM),
respectively, while from the 5HT3-antiserotonergic activity
analysis, IC50 of the 4b and 4f compounds was found to be
7.01 (16.04 lM) and 9.64 lg/mL (25.04 lM), respectively.
The standard drug Mepyramine displayed IC50 at 0.040 lM,
while Ondansetron showed IC50 at 0.24 lM. These studies
provide a novel lead molecule 4f with anti-inﬂammatory,
anti-histaminic and anti-serotonergic activities for further drug
development.4. Conclusions
In this work, we have prepared a series of bromopyrrole alka-
loid hybrids with aroyl hydrazone feature. The synthesized
hybrids were found to possess potent anti-inﬂammatoryacological evaluation of marine bromopyrrole alkaloid-based hybrids
p://dx.doi.org/10.1016/j.arabjc.2014.06.004
6 R.A. Rane et al.activities. Most active anti-inﬂammatory hybrids 4b and 4f
were further screened for their H1-antihistamic and 5-HT3
antiserotonergic potentials and were found to be active
(H1-antihistamic activity: 4b IC50 = 8.09 lg/mL and 4f
IC50 = 9.26; 5-HT3 antiserotonergic activity: 4b IC50 = 7.01
lg/mL and 4f IC50 = 9.64 lg/mL). Hence from this study we
can conclude that H1-antihistamic and 5-HT3 antiserotonergic
effects may be responsible for the anti-inﬂammatory activities
of these hybrids.Acknowledgements
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